Early use of daratumumab improves survival in RRMM
Thelimbic,
A combination of the CD38-directed monoclonal antibody daratumumab and a standard-of-care regimen significantly improves…
A combination of the CD38-directed monoclonal antibody daratumumab and a standard-of-care regimen significantly improves…
Combinations featuring the monoclonal antibodies daratumumab (Darzalex) or isatuximab-irfc (Sarclisa) have made notable…